Literature DB >> 16832050

Flanking sequences profoundly alter polyglutamine toxicity in yeast.

Martin L Duennwald1, Smitha Jagadish, Paul J Muchowski, Susan Lindquist.   

Abstract

Protein misfolding is the molecular basis for several human diseases. How the primary amino acid sequence triggers misfolding and determines the benign or toxic character of the misfolded protein remains largely obscure. Among proteins that misfold, polyglutamine (polyQ) expansion proteins provide an interesting case: Each causes a distinct neurodegenerative disease that selectively affects different neurons. However, all are broadly expressed and most become toxic when the glutamine expansion exceeds approximately 39 glutamine residues. The disease-causing polyQ expansion proteins differ profoundly in the amino acids flanking the polyQ region. We therefore hypothesized that these flanking sequences influence the specific toxic character of each polyQ expansion protein. Using a yeast model, we find that sequences flanking the polyQ region of human huntingtin exon I can convert a benign protein to a toxic species and vice versa. Further, we observe that flanking sequences can direct polyQ misfolding to at least two morphologically distinct types of polyQ aggregates. Very tight aggregates always are benign, whereas amorphous aggregates can be toxic. We thereby establish a previously undescribed systematic characterization of the influence of flanking amino acid sequences on polyQ toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832050      PMCID: PMC1544171          DOI: 10.1073/pnas.0604547103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila.

Authors:  Barbara L Apostol; Alexsey Kazantsev; Simona Raffioni; Katalin Illes; Judit Pallos; Laszlo Bodai; Natalia Slepko; James E Bear; Frank B Gertler; Steven Hersch; David E Housman; J Lawrence Marsh; Leslie Michels Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

2.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.

Authors:  Montserrat Arrasate; Siddhartha Mitra; Erik S Schweitzer; Mark R Segal; Steven Finkbeiner
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

3.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease.

Authors:  G A Graveland; R S Williams; M DiFiglia
Journal:  Science       Date:  1985-02-15       Impact factor: 47.728

4.  A network of protein interactions determines polyglutamine toxicity.

Authors:  Martin L Duennwald; Smitha Jagadish; Flaviano Giorgini; Paul J Muchowski; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

5.  Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain.

Authors:  Miguel Díaz-Hernández; Fernando Moreno-Herrero; Pilar Gómez-Ramos; María A Morán; Isidro Ferrer; Arturo M Baró; Jesús Avila; Félix Hernández; José J Lucas
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

Review 6.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

7.  A cell-based screen for drugs to treat Huntington's disease.

Authors:  Charity T Aiken; Allan J Tobin; Erik S Schweitzer
Journal:  Neurobiol Dis       Date:  2004-08       Impact factor: 5.996

8.  Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation.

Authors:  Gregor Schaffar; Peter Breuer; Raina Boteva; Christian Behrends; Nikolay Tzvetkov; Nadine Strippel; Hideki Sakahira; Katja Siegers; Manajit Hayer-Hartl; F Ulrich Hartl
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

9.  Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction.

Authors:  Zheng-Hong Qin; Yumei Wang; Ellen Sapp; Benjamin Cuiffo; Erich Wanker; Michael R Hayden; Kimberly B Kegel; Neil Aronin; Marian DiFiglia
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  SUMO modification of Huntingtin and Huntington's disease pathology.

Authors:  Joan S Steffan; Namita Agrawal; Judit Pallos; Erica Rockabrand; Lloyd C Trotman; Natalia Slepko; Katalin Illes; Tamas Lukacsovich; Ya-Zhen Zhu; Elena Cattaneo; Pier Paolo Pandolfi; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

View more
  149 in total

1.  Protofilament Structure and Supramolecular Polymorphism of Aggregated Mutant Huntingtin Exon 1.

Authors:  Jennifer C Boatz; Talia Piretra; Alessia Lasorsa; Irina Matlahov; James F Conway; Patrick C A van der Wel
Journal:  J Mol Biol       Date:  2020-06-27       Impact factor: 5.469

Review 2.  Polyglutamine misfolding in yeast: toxic and protective aggregation.

Authors:  Martin L Duennwald
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

3.  Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool.

Authors:  Maya A Olshina; Lauren M Angley; Yasmin M Ramdzan; Jinwei Tang; Michael F Bailey; Andrew F Hill; Danny M Hatters
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

Review 4.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

Review 5.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

6.  Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.

Authors:  Mingchen Chen; Peter G Wolynes
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-11       Impact factor: 11.205

Review 7.  Replicative aging in yeast: the means to the end.

Authors:  K A Steinkraus; M Kaeberlein; B K Kennedy
Journal:  Annu Rev Cell Dev Biol       Date:  2008       Impact factor: 13.827

8.  Aneuploidy causes proteotoxic stress in yeast.

Authors:  Ana B Oromendia; Stacie E Dodgson; Angelika Amon
Journal:  Genes Dev       Date:  2012-12-07       Impact factor: 11.361

9.  Differences in prion strain conformations result from non-native interactions in a nucleus.

Authors:  Yumiko Ohhashi; Kazuki Ito; Brandon H Toyama; Jonathan S Weissman; Motomasa Tanaka
Journal:  Nat Chem Biol       Date:  2010-01-17       Impact factor: 15.040

10.  Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1.

Authors:  Can Kayatekin; Kent E S Matlack; William R Hesse; Yinghua Guan; Sohini Chakrabortee; Jenny Russ; Erich E Wanker; Jagesh V Shah; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.